Researchers have developed software that can be run on desktop computers, iPads, and iPhones to generate, in real time, whether a radical cystectomy patient is likely to be rehospitalized and when the urologist should follow up with the patient.
In a recent study about the decision support tool REACT: Readmission Elimination App for Cystectomy Treatment, authors write that the tool aims to quickly identify clinical deterioration. More customization and testing are needed, however, before urologists can begin using it.
REACT uses models that analyze published data to come up with optimal timing for office visits and phone calls, so that urologists are most likely to identify radical cystectomy patients at high readmission risk before those readmissions occur. The authors calibrated and validated REACT using radical cystectomy patient data from 2009 to 2010 Healthcare Cost and Utilization Project State Inpatient Databases, as well as the University of Michigan’s bladder cancer database from 2007 to 2011.
This is an area ripe for innovation, according to study author and IHPI member, Tudor Borza.
“Novel approaches are paramount to decreasing readmissions following cystectomy. Despite multiple efforts by clinical leaders, readmission rates after cystectomy have remained stable at around 25% over the past decade,” Dr. Borza said. “This decision tool provides an additional dimension that can augment traditional care and reduce readmissions.”